Prysmian Group North Europe AB financials
Prysmian Group North Europe AB
Country: IT Reporting currency: EUR Latest annual report: 2021-12-31
LEI:
529900XU5693SRXKDO71 Financial statements
(EUR, as reported — unscaled; 113 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | €13.09B | €10.18B |
| Other income | €125.0M | €99.0M |
| Employee benefits expense | €1.49B | €1.41B |
| Raw materials & consumables used | €8.91B | €6.46B |
| Operating profit (EBIT) | €572.0M | €353.0M |
| Finance costs | €785.0M | €569.0M |
| Profit before tax | €476.0M | €252.0M |
| Income tax expense | €166.0M | €78.0M |
| Profit for the year | €310.0M | €174.0M |
| — attributable to owners | €308.0M | €178.0M |
| — attributable to NCI | -€2.0M | €4.0M |
| Total comprehensive income | €716.0M | -€148.0M |
| Per share | ||
| Basic EPS | €1.17 | €0.68 |
| Diluted EPS | €1.17 | €0.68 |
| Free cash flow / share | €1.96 | €1.82 |
| Cash flow statement | ||
| Net cash from operating activities | €777.0M | €705.0M |
| Income taxes paid | €120.0M | €142.0M |
| Net cash from investing activities | -€582.0M | -€250.0M |
| Purchase of PP&E (capex) | €258.0M | €240.0M |
| Purchase of intangibles | €25.0M | €22.0M |
| Net cash from financing activities | €335.0M | -€325.0M |
| Dividends paid | €134.0M | €70.0M |
| Proceeds from borrowings | €844.0M | €0 |
| Repayments of borrowings | €269.0M | €117.0M |
| Balance sheet | ||
| Total assets | €12.02B | €9.93B |
| Non-current assets | €5.63B | €5.25B |
| Property, plant & equipment | €2.79B | €2.65B |
| Intangible assets & goodwill | €1.64B | €1.51B |
| Current assets | €6.39B | €4.67B |
| Inventories | €2.05B | €1.53B |
| Trade & other receivables | €1.62B | €1.37B |
| Cash & equivalents | €1.70B | €1.16B |
| Total equity | €3.09B | €2.42B |
| — attributable to owners | €2.92B | €2.26B |
| Non-controlling interests | €174.0M | €164.0M |
| Non-current liabilities | €3.32B | €3.80B |
| Long-term borrowings | €2.61B | €3.04B |
| Current liabilities | €5.61B | €3.70B |
| Deferred tax liabilities | €188.0M | €195.0M |
| Derived metrics | ||
| Free cash flow | €519.0M | €465.0M |
| Operating margin | 4.4% | 3.5% |
| Net margin | 2.4% | 1.7% |
| Return on equity | 10.0% | 7.2% |
| Cash conversion ratio | 2.51× | 4.05× |
| Capex coverage | 3.01× | 2.94× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€449.0M | -€101.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €335.0M | €393.0M |
| Adjustments For Finance Costs | €96.0M | €101.0M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €2.0M | €20.0M |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | €13.0M | -€4.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€15.0M | -€13.0M |
| Adjustments For Provisions | €34.0M | -€150.0M |
| Adjustments For Sharebased Payments | €33.0M | €31.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €27.0M | €18.0M |
| Cash and Cash Equivalents Classified As Part of Disposal Group Held For Sale | €0 | €1.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.70B | €1.16B |
| Changes In Inventories of Finished Goods and Work In Progress | -€229.0M | -€69.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €13.0M | -€20.0M |
| Comprehensive Income Attributable To Owners of Parent | €703.0M | -€128.0M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €1.12B | €127.0M |
| Current Derivative Financial Assets | €128.0M | €82.0M |
| Current Derivative Financial Liabilities | €42.0M | €46.0M |
| Current Financial Assets At Fair Value Through Profit Or Loss | €244.0M | €20.0M |
| Current Financial Assets Measured At Fair Value Through Other Comprehensive Income | €11.0M | €11.0M |
| Current Tax Liabilities Current | €54.0M | €25.0M |
| Deferred Tax Assets | €182.0M | €207.0M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €335.0M | €393.0M |
| Dividends Received Classified As Operating Activities | €8.0M | €8.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €8.0M | -€36.0M |
| Equity and Liabilities | €12.02B | €9.93B |
| Finance Income | €689.0M | €468.0M |
| Gains Losses On Cash Flow Hedges Before Tax | €83.0M | €78.0M |
| Gains Losses On Change In Fair Value of Derivatives | €13.0M | -€4.0M |
| Income Tax Relating To Hedges of Investments In Equity Instruments of Other Comprehensive Income | €20.0M | €23.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €9.0M | -€9.0M |
| Increase Decrease In Cash and Cash Equivalents | €538.0M | €94.0M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Exercise of Options | €33.0M | €31.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €1.0M | €1.0M |
| Intangible Assets Other Than Goodwill | €494.0M | €489.0M |
| Interest Paid Classified As Financing Activities | €79.0M | €86.0M |
| Investment Accounted For Using Equity Method | €360.0M | €312.0M |
| Issue of Convertible Instruments | €49.0M | — |
| Issued Capital | €27.0M | €27.0M |
| Liabilities | €8.93B | €7.51B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €0 | €2.0M |
| Noncurrent Derivative Financial Assets | €105.0M | €44.0M |
| Noncurrent Derivative Financial Liabilities | €26.0M | €13.0M |
| Noncurrent Financial Assets At Amortised Cost | €3.0M | €4.0M |
| Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income | €13.0M | €13.0M |
| Noncurrent Provisions For Employee Benefits | €446.0M | €506.0M |
| Other Comprehensive Income | €406.0M | -€322.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €60.0M | -€28.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €63.0M | €55.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €292.0M | -€358.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €51.0M | -€19.0M |
| Other Current Payables | €1.19B | €995.0M |
| Other Current Receivables | €627.0M | €492.0M |
| Other Expense By Nature | €1.83B | €1.58B |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€28.0M | -€53.0M |
| Other Longterm Provisions | €46.0M | €39.0M |
| Other Noncurrent Payables | €6.0M | €6.0M |
| Other Noncurrent Receivables | €34.0M | €30.0M |
| Other Shortterm Provisions | €607.0M | €552.0M |
| Proceeds From Issuing Other Equity Instruments | €1.0M | €1.0M |
| Proceeds From Sales of Interests In Associates | €0 | €9.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €8.0M | €9.0M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €0 | €2.0M |
| Purchase of Financial Instruments Classified As Investing Activities | €224.0M | €3.0M |
| Revenue From Contracts With Customers | €12.74B | €10.02B |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €27.0M | €18.0M |
| Trade and Other Current Payables To Trade Suppliers | €2.59B | €1.96B |
Methodology
Every line item above is a fact tagged in Prysmian Group North Europe AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.